Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
parmax pharma limited stock

Parmax Pharma Limited Share Price

48.25 -0.72 (-1.46%)
Nov 21 2024 03:20 PM Pharmaceuticals NSE: PARMAX

Parmax Pharma Limited Share Price Update

As of the latest trading session, Parmax Pharma Limited share price is currently at 48.25, which is down by -0.72 from its previous closing. Today, the stock has fluctuated between 48.25 and 49.76. Over the past year, Parmax Pharma Limited has achieved a return of 52.34 %. In the last month alone, the return has been 14.06 %. Read More...

Parmax Pharma Limited Performance

Day Range

Low48.25 High49.76
48.25

52 Week Range

Low 24.18 High 54.00
48.25

Parmax Pharma Limited Share Price

540359

PARMAX

img img img img
No Data Available

Open Price

48.98

Prev. Close

48.98

Volume (Shares)

1052.00

Total traded value

.52

Upper Circuit

51.42

Lower Circuit

46.54

Note: The current prices & values are delayed, Login to your account for live updates.

Parmax Pharma Limited Fundamentals


(Standalone)

Market Cap (Cr) 18.10
PE Ratio (TTM) -5.30
Book Value / Share -2.16
Beta 0.39
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.22

Parmax Pharma Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 9.28
Operating Expense 9.61
Net Profit -0.22
Net Profit Margin (%) -2.37
Earnings Per Share (EPS) -0.58
EBITDA 0.31
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 7.82
Operating Expense 7.81
Net Profit 0.01
Net Profit Margin (%) 0.12
Earnings Per Share (EPS) 0.03
EBITDA 0.52
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.26
Operating Expense 5.62
Net Profit -1.45
Net Profit Margin (%) -34.03
Earnings Per Share (EPS) -3.88
EBITDA -0.79
Effective Tax Rate (%) -6.61
Particulars DEC 2023 (Values in Cr)
Revenue 1.33
Operating Expense 3.09
Net Profit -1.75
Net Profit Margin (%) -131.57
Earnings Per Share (EPS) -4.68
EBITDA -1.14
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.07
Operating Expense 5.43
Net Profit -1.37
Net Profit Margin (%) -33.66
Earnings Per Share (EPS) -3.66
EBITDA -0.76
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 11.05
Operating Expense 16.76
Net Profit -5.75
Net Profit Margin (%) -52.03
Earnings Per Share (EPS) -15.37
EBITDA -3.33
Effective Tax Rate (%) -1.59
Particulars MAR 2023 (Values in Cr)
Revenue 15.42
Operating Expense 15.42
Net Profit -0.10
Net Profit Margin (%) -0.64
Earnings Per Share (EPS) -0.28
EBITDA 2.30
Effective Tax Rate (%) 299.99
Particulars MAR 2022 (Values in Cr)
Revenue 18.25
Operating Expense 18.01
Net Profit 0.14
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.38
EBITDA 2.62
Effective Tax Rate (%) 53.33
Particulars MAR 2021 (Values in Cr)
Revenue 26.20
Operating Expense 25.08
Net Profit 0.75
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 2.02
EBITDA 3.50
Effective Tax Rate (%) 37.19
Particulars MAR 2020 (Values in Cr)
Revenue 20.93
Operating Expense 20.30
Net Profit 0.43
Net Profit Margin (%) 2.05
Earnings Per Share (EPS) 1.15
EBITDA 1.87
Effective Tax Rate (%) 41.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.91
EBITDA Margin -30.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.16
ROE % -1.69
ROCE % 3.76
Total Debt to Total Equity 0.89
EBITDA Margin 14.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.39
ROE % 2.38
ROCE % 6.04
Total Debt to Total Equity 0.94
EBITDA Margin 14.41
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.07
ROE % 13.79
ROCE % 14.26
Total Debt to Total Equity 1.02
EBITDA Margin 13.44
Particulars MAR 2020 (Values in Cr)
Book Value / Share 11.38
ROE % 8.88
ROCE % 8.40
Total Debt to Total Equity 1.11
EBITDA Margin 8.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.33
Total Liabilities 15.33
Total Equity 0.07
Share Outstanding 5100800
Price to Book Ratio 178.00
Return on Assets (%) -37.69
Return on Capital (%) -96.68
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 17.61
Total Liabilities 17.61
Total Equity 5.85
Share Outstanding 44512
Price to Book Ratio 2.31
Return on Assets (%) -0.59
Return on Capital (%) -1.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.05
Total Assets 17.97
Total Liabilities 17.97
Total Equity 5.95
Share Outstanding 4451150
Price to Book Ratio 3.05
Return on Assets (%) 0.78
Return on Capital (%) 1.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.54
Total Assets 22.72
Total Liabilities 22.72
Total Equity 5.81
Share Outstanding 4451150
Price to Book Ratio 2.72
Return on Assets (%) 3.31
Return on Capital (%) 6.7
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.76
Total Assets 21.06
Total Liabilities 21.06
Total Equity 5.06
Share Outstanding 4451150
Price to Book Ratio 0.00
Return on Assets (%) 2.03
Return on Capital (%) 4.25
Particulars MAR 2024 (Values in Cr)
Net Income -5.65
Cash from Operations -0.19
Cash from Investing -1.58
Cash from Financing 1.42
Net change in Cash -0.34
Free Cash Flow 1.29
Particulars MAR 2023 (Values in Cr)
Net Income 0.04
Cash from Operations 0.33
Cash from Investing -0.93
Cash from Financing -0.04
Net change in Cash -0.64
Free Cash Flow 1.26
Particulars MAR 2022 (Values in Cr)
Net Income 0.30
Cash from Operations 0.74
Cash from Investing -1.53
Cash from Financing -0.91
Net change in Cash -1.69
Free Cash Flow 2.28
Particulars MAR 2021 (Values in Cr)
Net Income 1.20
Cash from Operations 3.52
Cash from Investing -3.14
Cash from Financing 0.39
Net change in Cash 0.77
Free Cash Flow 6.67
Particulars MAR 2020 (Values in Cr)
Net Income 0.73
Cash from Operations 2.82
Cash from Investing -2.39
Cash from Financing -0.22
Net change in Cash 0.20
Free Cash Flow 5.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2436.25 51.47 24.67 41271.55 1565.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 48.50
  • 26 Days 45.60
  • 10 Days 48.10
  • 50 Days 43.90
  • 12 Days 47.90
  • 100 Days 40.60
  • 20 Days 46.90
  • 200 Days 32.70
47.71
PIVOT
First Resistance 50.27
Second Resistance 51.57
Third Resistance 54.13
First Support 46.41
Second Support 43.85
Third Support 42.55
RSI 68.54
MACD 2.30
Commodity Channel Index (CCI) 49.72
ADX 46.38
Williams % R -27.65

Over 1 Month

down

14.06

Over 3 Months

down

41.56

Over 6 Months

down

59.49

Over 1 Year

down

52.34

Over 3 Years

down

5.67

Over 5 Years

down

20.85

Parmax Pharma Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Parmax Pharma Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
69.19
Promoter Holdings
30.8
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Alkesh Mahasukh Gopani Shareholding of Promoter and Promoter Group 670380.0 17.92
Vipul Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 481370.0 12.87
Gosalia Meena Alkesh Public Shareholding 474800.0 12.69
Pradeep Ramniklal Gosalia Public Shareholding 302714.0 8.09
Umang Alkesh Gosalia Public Shareholding 200000.0 5.35
Gosalia Nimit P Public Shareholding 90000.0 2.41
Bharti Deepak Mehta Public Shareholding 57466.0 1.54
Gosalia Vandana P Public Shareholding 40000.0 1.07
Pravina Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 700.0 0.02
Mahasukhlal Gopani Shareholding of Promoter and Promoter Group 0.0 0.0

Parmax Pharma Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Parmax Pharma Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Parmax Pharma Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Parmax Pharma Ltd?

Answer Field

The share price of Parmax Pharma Ltd for NSE is ₹ 0.00 and for BSE is ₹ 48.25.

What is the Market Cap of Parmax Pharma Ltd?

Answer Field

The market cap of Parmax Pharma Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 18.10 Cr. as of now.

What is the 52 Week High and Low of Parmax Pharma Ltd?

Answer Field

The 52 Week High and Low of Parmax Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 54.00 and ₹ 24.18.

How to Buy Parmax Pharma Ltd share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Parmax Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 52.34%.

What is the Current Share Price of Parmax Pharma Ltd?

Answer Field

Parmax Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 48.25 as on Nov 21 2024 03:20 PM.

What is the Market Cap of Parmax Pharma Ltd Share?

Answer Field

The market cap of Parmax Pharma Ltd for NSE ₹ 0.0 & for BSE ₹ 18.10 as on Nov 21 2024 03:20 PM.

What is the P/E Ratio of Parmax Pharma Ltd Share?

Answer Field

As on Nov 21 2024 03:20 PM the price-to-earnings (PE) ratio for Parmax Pharma Ltd share is -5.30.

What is the PB ratio of Parmax Pharma Ltd Share?

Answer Field

As on Nov 21 2024 03:20 PM, the price-to-book (PB) ratio for Parmax Pharma Ltd share is -2.16.

How to Buy Parmax Pharma Ltd Share?

Answer Field

You can trade in Parmax Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Parmax Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Parmax Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Parmax Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader